112 related articles for article (PubMed ID: 2803313)
1. Complete deficiency of 20 KDa homologous restriction factor (HRF20) and restoration with purified HRF20.
Okada N; Harada R; Taguchi R; Okada H
Biochem Biophys Res Commun; 1989 Oct; 164(1):468-73. PubMed ID: 2803313
[TBL] [Abstract][Full Text] [Related]
2. Erythrocytes of patients with paroxysmal nocturnal haemoglobinuria acquire resistance to complement attack by purified 20-kD homologous restriction factor.
Okada N; Harada R; Okada H
Clin Exp Immunol; 1990 Apr; 80(1):109-13. PubMed ID: 1691059
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric analysis of homologous restriction factor 20KD (HRF20) expression on progeny cells during differentiation from haemopoietic progenitors in paroxysmal nocturnal haemoglobinuria.
Nishimura T; Kanamaru A; Kakishita E; Nagai K
Br J Haematol; 1995 Jun; 90(2):293-9. PubMed ID: 7794748
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum.
Wilcox LA; Ezzell JL; Bernshaw NJ; Parker CJ
Blood; 1991 Aug; 78(3):820-9. PubMed ID: 1713516
[TBL] [Abstract][Full Text] [Related]
5. Differential susceptibility of type III erythrocytes of paroxysmal nocturnal hemoglobinuria to lysis mediated by complement and perforin.
Jiang S; Persechini PM; Rosse WF; Perussia B; Young JD
Biochem Biophys Res Commun; 1989 Jul; 162(1):316-25. PubMed ID: 2751655
[TBL] [Abstract][Full Text] [Related]
6. A simplified assay for the specific diagnosis of paroxysmal nocturnal hemoglobinuria: detection of DAF(CD55)- and HRF20(CD59)- erythrocytes in microtyping cards.
Nilsson B; Hagström U; Englund A; Säfwenberg J
Vox Sang; 1993; 64(1):43-6. PubMed ID: 7680511
[TBL] [Abstract][Full Text] [Related]
7. Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene.
Motoyama N; Okada N; Yamashina M; Okada H
Eur J Immunol; 1992 Oct; 22(10):2669-73. PubMed ID: 1382994
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.
Zalman LS; Wood LM; Frank MM; Müller-Eberhard HJ
J Exp Med; 1987 Feb; 165(2):572-7. PubMed ID: 2434597
[TBL] [Abstract][Full Text] [Related]
9. Expression of cryptantigen Th on paroxysmal nocturnal hemoglobinuria erythrocytes in association with a hemolytic exacerbation.
Nakakuma H; Hidaka M; Nagakura S; Nishimura Y; Iwamoto N; Horikawa K; Kawaguchi T; Kagimoto T; Takatsuki K
J Clin Invest; 1995 Jul; 96(1):201-6. PubMed ID: 7542278
[TBL] [Abstract][Full Text] [Related]
10. Characterization of homologous restriction factor (HRF20) in human skin and leucocytes.
Sayama K; Shiraishi S; Shirakata Y; Kobayashi Y; Okada N; Okada H; Miki Y
Clin Exp Immunol; 1990 Nov; 82(2):355-8. PubMed ID: 2242615
[TBL] [Abstract][Full Text] [Related]
11. Unique expression of HRF20 (CD59) in human nervous tissue.
Akatsu H; Yamada T; Okada N; Yamamoto T; Yamashina M; Okada H
Microbiol Immunol; 1997; 41(4):321-9. PubMed ID: 9159406
[TBL] [Abstract][Full Text] [Related]
12. Species-specific restriction of complement by HRF20 (CD59) generated by cDNA transfection.
Takizawa H; Takahashi K; Murakami T; Okada N; Okada H
Eur J Immunol; 1992 Jul; 22(7):1943-6. PubMed ID: 1378024
[TBL] [Abstract][Full Text] [Related]
13. HRF20, a membrane inhibitor of complement attack, does not protect cells from the cytotoxic reaction by lymphokine activated killer cells.
Okada H; Okada N; Hideshima T
Biochem Biophys Res Commun; 1990 Sep; 171(2):717-21. PubMed ID: 1698362
[TBL] [Abstract][Full Text] [Related]
14. Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy.
Hill A; Ridley SH; Esser D; Oldroyd RG; Cullen MJ; Kareclas P; Gallagher S; Smith GP; Richards SJ; White J; Smith RA; Hillmen P
Blood; 2006 Mar; 107(5):2131-7. PubMed ID: 16322479
[TBL] [Abstract][Full Text] [Related]
15. [Paroxysmal nocturnal hemoglobinuria (PNH) deficiency of major complement-regulatory membrane proteins on erythrocytes].
Ninomiya H; Kobayashi T; Abe T
Rinsho Ketsueki; 1991 Jun; 32(6):612-7. PubMed ID: 1716325
[TBL] [Abstract][Full Text] [Related]
16. Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients.
Nagakura S; Nakakuma H; Horikawa K; Hidaka M; Kagimoto T; Kawakita M; Tomita M; Takatsuki K
Am J Hematol; 1993 May; 43(1):14-8. PubMed ID: 7686331
[TBL] [Abstract][Full Text] [Related]
17. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.
Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF
J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544
[TBL] [Abstract][Full Text] [Related]
18. Implication of membrane factors other than DAF and CD59 in complement-mediated lysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
Hatanaka M; Inai S; Matsumoto M; Miyagawa S; Masaoka T; Kanamaru A; Kawakita M; Yonemura Y; Sugita Y; Seya T
Clin Immunol Immunopathol; 1993 Oct; 69(1):52-9. PubMed ID: 7691453
[TBL] [Abstract][Full Text] [Related]
19. [Immunocytochemical staining of decay-accelerating factor (DAF) on erythrocytes: paroxysmal nocturnal hemoglobinuria (PNH)].
Kobayashi T; Nakazawa M; Sato Y; Tomiyama J; Ninomiya H; Abe T; Terasawa T; Shichishima T; Fujita T
Rinsho Ketsueki; 1992 Feb; 33(2):162-6. PubMed ID: 1378912
[TBL] [Abstract][Full Text] [Related]
20. [Expression of GPI-anchor proteins during the differentiation from hematopoietic progenitors in patients with paroxysmal nocturnal hemoglobinuria].
Kanamaru A; Nishimura T
Rinsho Ketsueki; 1994 Apr; 35(4):358-63. PubMed ID: 8028180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
